Milestone Scientific Inc.
General ticker "MLSS" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $28.2M (TTM average)
Milestone Scientific Inc. follows the US Stock Market performance with the rate: 41.1%.
Estimated limits based on current volatility of 4.5%: low 0.32$, high 0.35$
Factors to consider:
- Total employees count: 15 (-11.8%) as of 2025
- US accounted for 9.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Need additional capital, Going concern doubt, Single product demand, Technology development, Manufacturing disruptions
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.18$, 0.53$]
- 2026-12-31 to 2027-12-31 estimated range: [0.18$, 0.50$]
Financial Metrics affecting the MLSS estimates:
- Positive: with PPE of -4.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Positive: -16.84 < Industry operating profit margin (median), % of -7.42
- Positive: Inventory ratio change, % of -0.44 <= -0.37
- Positive: 34.41 < Shareholder equity ratio, % of 36.03 <= 42.26
- Positive: 0.90 < Industry operating cash flow per share per price (median), % of 1.58
- Positive: -0.14 < Investing cash flow per share per price, % of -0.06
Short-term MLSS quotes
Long-term MLSS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $9.83MM | $8.63MM | $8.97MM |
| Operating Expenses | $16.93MM | $15.39MM | $14.67MM |
| Operating Income | $-7.11MM | $-6.76MM | $-5.70MM |
| Non-Operating Income | $0.13MM | $2.04MM | $-0.03MM |
| R&D Expense | $0.70MM | $0.86MM | $0.45MM |
| Income(Loss) | $-6.98MM | $-4.71MM | $-5.72MM |
| Net Income(Loss)* | $-6.93MM | $-4.71MM | $-5.72MM |
| Stockholders Equity | $8.01MM | $5.83MM | $2.81MM |
| Inventory | $2.64MM | $3.71MM | $3.78MM |
| Assets | $11.37MM | $9.80MM | $7.81MM |
| Operating Cash Flow | $-5.33MM | $-2.92MM | $-2.92MM |
| Capital expenditure | $0.00MM | $0.01MM | $0.02MM |
| Investing Cash Flow | $-2.97MM | $2.97MM | $-0.02MM |
| Financing Cash Flow | $2.56MM | $0.23MM | $0.79MM |
| Earnings Per Share** | $-0.10 | $-0.06 | $-0.07 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.